Form 4: Director Michael Farrell Increases ZBH Phantom Stock

Director Michael J. Farrell acquired 420.97 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan.

Summary

• Director Michael J. Farrell acquired 420.97 phantom stock units on March 31, 2026.
• The units were acquired under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The conversion price for these units is 1-for-1.
• Following this transaction, the director holds a total of 18,245.033 phantom stock units.
• These units are to be settled in cash upon the cessation of the director's service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Director demonstrates continued alignment with company performance through participation in the deferred compensation plan.

Negatives

• None identified.

Risks

• Value of phantom stock units is tied to the future performance of Zimmer Biomet common stock.

Future Outlook

The units will be settled in cash in a lump sum within sixty days after the reporting person ceases to serve as a Director.

Management Comments

• The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Industry Context

StockSavvy.ai notes that director participation in deferred compensation plans is a standard corporate governance practice, signaling long-term commitment to the issuer's equity performance without immediate cash outlay.

Comparison to Industry Standards

• The use of phantom stock units for non-employee director compensation is consistent with standard practices among large-cap medical device companies.
• The 1-for-1 conversion ratio is standard for deferred compensation plans in the healthcare sector.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation-related transaction.

Next Steps

• Settlement of phantom stock units in cash upon the director's eventual departure from the board.

Key Dates

Keywords

Zimmer Biomet, ZBH, Form 4, Insider Trading, Director Compensation, Phantom Stock